glp-1 news 48 hours Shots or pills — which works better for weight loss? 💊💉, A new pill has officially entered the conversation, offering a needle-free option for patients. But how does it compare to injectable Doctors and patients across social

The UK Regulatory and Access Landscape For retatrutide to become a reality for UK patients, it must navigate a complex multi-stage approval and commissioning process

Investigators routinely incorporate it into receptor-binding assays, signaling-pathway studies, comparative pharmacology screens, and exploratory work involving regenerative, metabolic, or neuroprotective endpoints

Antidiabetic agents for treatment of Parkinsons disease: a meta-analysis

The oral segment dominated the market in 2024 and is expected to grow with a significant CAGR of 3.4% over the analysis period

Xianchu L, Kang L, Beiwan D, Huan P, Ming L

H.SongC